E. Florou

Early Treatment of COVID-19 Pneumonia with Anakinra Guided by Urokinase Plasminogen Receptor

M. Netea, S. Ktena, G. Ippolito, 2021 .

Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

M. Netea, S. Ktena, E. Nicastri, 2021, Nature medicine.

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

M. Netea, S. Ktena, G. Ippolito, 2021, Nature Medicine.

Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

M. Netea, S. Ktena, E. Nicastri, 2021, Nature medicine.